artery technology

Hangzhou Artery Technology Co., Ltd. is a top-tier computational application research center in China, internationally leading in large-scale computing, and possesses a set of globally efficient fluid simulation algorithm codes with complete independent intellectual property rights. Artery Technology was established in May 2018, focusing on solving complex problems in aerospace, weather forecasting, and biomedical engineering through high-performance computing based on large-scale complex computational applications. Currently, it has achieved personalized, non-invasive, high-precision, and rapid disease diagnosis in the field of biomedical engineering. Artery Technology is a high-tech company led by Professor Xiaochuan Cai, a scholar of the "National Thousand Talents Plan" and a renowned international scientist in the computational field, along with an internationally acclaimed research team with over thirty years of experience in fluid mechanics, biomedical engineering, and high-performance computing. This team has led multiple projects funded by the U.S. National Science Foundation, China's Ministry of Science and Technology National Key R&D Program, and the National Natural Science Foundation of China, publishing over a hundred papers in top journals related to computational mathematics, biomedical engineering, and medicine. In August 2020, the company obtained its first medical device registration certificate for three-dimensional reconstruction software for arterial medical imaging.